Cita APA (7a ed.)

Adhikari, H., Kattan, W. E., Kumar, S., Zhou, P., Hancock, J. F., & Counter, C. M. (2021). Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. Nature Portfolio.

Cita Chicago Style (17a ed.)

Adhikari, Hema, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, y Christopher M. Counter. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Adhikari, Hema, et al. Oncogenic KRAS Is Dependent upon an EFR3A-PI4KA Signaling Axis for Potent Tumorigenic Activity. Nature Portfolio, 2021.